Certificate of Analysis
Third Party Tested • ISO/IEC 17025 Accredited • Premium Quality
Purity: 99.68% (✓ Passed Full QC Panel)
Specification Specification
| Variant | |
| CJC-1295 | / |
| Ipamorelin | (5mg / 5mg) |
| Lot # | CIP0001 |
| Labeled | 10mg blend |
| Actual | 10.43mg |
| CJC-1295 | 5.11mg |
| Ipamorelin | 5.32mg |
| Tested | Jun 10, 2026 |
| Full QC Panel | 8× tested |
| Purity (HPLC) | 99.68% |
| Net Peptide Content | 10.43mg |
| Identity (HPLC) | |
| CJC-1295 | + |
| Ipamorelin | |
| Fentanyl Screen | Not Detected |
| HPLC Conformity | mean 99.39% |
| Heavy Metals (ICP-MS) | Not Detected |
| Sterility (PCR) | No Growth |
| Endotoxin (USP <85>) | < 0.05 EU/mLISO/IEC 17025 Accredited99.94%Purity |
Specification Specification
| Variant | |
| CJC-1295 | / |
| Ipamorelin | (5mg / 5mg) |
| Lot # | D3123 |
| Labeled | 10mg blend |
| Actual | 12.02mg total |
| Ipamorelin | 6.13mg |
| CJC-1295 | 5.89mg |
| Tested | Feb 4, 2026 |
Frequently Researched Together
Growth factor research compounds
CJC-1295 (No DAC)
GHRH Analog Component
| Other names | Mod GRF 1-29, Modified GRF |
| Type | GHRH analog |
| Amino Acids | 29 |
| Molecular Weight | ~3,367 g/molMechanismGHRH receptor agonist |
| Half-life | (No DAC)30 min – 2 hoursTeichman et al., 2006 |
Ipamorelin
Selective GHRP Component
| Type | Growth hormone secretagogue |
| Amino Acids | 5 (pentapeptide) |
| Molecular Weight | 711.85 g/mol |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2MechanismGhrelin receptor (GHSR-1a) agonistSelectivityNo cortisol/prolactin elevationRaun et al., 1998 |
